Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 514

1.

What are the support needs of nurses providing emergency care in rural settings as reported in the literature? A scoping review.

Burrows GL, Calleja P, Cooke M.

Rural Remote Health. 2019 May;19(2):4805. doi: 10.22605/RRH4805. Epub 2019 May 15.

2.

MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection.

Rozanov DV, Rozanov ND, Chiotti KE, Reddy A, Wilmarth PA, David LL, Cha SW, Woo S, Pevzner P, Bafna V, Burrows GG, Rantala JK, Levin T, Anur P, Johnson-Camacho K, Tabatabaei S, Munson DJ, Bruno TC, Slansky JE, Kappler JW, Hirano N, Boegel S, Fox BA, Egelston C, Simons DL, Jimenez G, Lee PP, Gray JW, Spellman PT.

J Proteomics. 2018 Mar 30;176:13-23. doi: 10.1016/j.jprot.2018.01.004. Epub 2018 Jan 10.

3.

Dynamics in the global protected-area estate since 2004.

Lewis E, MacSharry B, Juffe-Bignoli D, Harris N, Burrows G, Kingston N, Burgess ND.

Conserv Biol. 2019 Jun;33(3):570-579. doi: 10.1111/cobi.13056. Epub 2018 Oct 17.

PMID:
29168224
4.

Validation of the (Troponin-only) Manchester ACS decision aid with a contemporary cardiac troponin I assay.

Va Den Berg P, Burrows G, Lewis P, Carley S, Body R.

Am J Emerg Med. 2018 Apr;36(4):602-607. doi: 10.1016/j.ajem.2017.09.032. Epub 2017 Sep 23.

PMID:
29079376
5.

Mycobacterium tuberculosis Proteome Response to Antituberculosis Compounds Reveals Metabolic "Escape" Pathways That Prolong Bacterial Survival.

Danelishvili L, Shulzhenko N, Chinison JJJ, Babrak L, Hu J, Morgun A, Burrows G, Bermudez LE.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00430-17. doi: 10.1128/AAC.00430-17. Print 2017 Jul.

6.

Troponin-only Manchester Acute Coronary Syndromes (T-MACS) decision aid: single biomarker re-derivation and external validation in three cohorts.

Body R, Carlton E, Sperrin M, Lewis PS, Burrows G, Carley S, McDowell G, Buchan I, Greaves K, Mackway-Jones K.

Emerg Med J. 2017 Jun;34(6):349-356. doi: 10.1136/emermed-2016-205983. Epub 2016 Aug 26.

7.

Accidental ice-burn.

Stagnell S, Burrows G.

Br Dent J. 2016 Aug 26;221(4):149. doi: 10.1038/sj.bdj.2016.580. No abstract available.

PMID:
27561557
8.

Solution-Phase Crosstalk and Regulatory Interactions Between Multipotent Adult Progenitor Cells and Peripheral Blood Mononuclear Cells.

Burrows GG, Van't Hof W, Reddy AP, Wilmarth PA, David LL, Raber A, Bogaerts A, Timmerman L, Pinxteren J, Roobrouck VD, Deans RJ, Maziarz RT.

Stem Cells Transl Med. 2015 Dec;4(12):1436-49. doi: 10.5966/sctm.2014-0225. Epub 2015 Oct 22.

9.

High-sensitivity cardiac troponin t concentrations below the limit of detection to exclude acute myocardial infarction: a prospective evaluation.

Body R, Burrows G, Carley S, Cullen L, Than M, Jaffe AS, Lewis PS.

Clin Chem. 2015 Jul;61(7):983-9. doi: 10.1373/clinchem.2014.231530. Epub 2015 May 15.

10.

Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a sensitive troponin I assay.

Body R, Burrows G, Carley S, Lewis PS.

Ann Clin Biochem. 2015 Sep;52(Pt 5):543-9. doi: 10.1177/0004563215576976. Epub 2015 Feb 23.

PMID:
25713467
11.

Treatment of postnatal depression with cognitive behavioural therapy, sertraline and combination therapy: a randomised controlled trial.

Milgrom J, Gemmill AW, Ericksen J, Burrows G, Buist A, Reece J.

Aust N Z J Psychiatry. 2015 Mar;49(3):236-45. doi: 10.1177/0004867414565474. Epub 2015 Jan 13.

PMID:
25586754
12.

The Manchester Acute Coronary Syndromes (MACS) decision rule: validation with a new automated assay for heart-type fatty acid binding protein.

Body R, Burrows G, Carley S, Lewis PS.

Emerg Med J. 2015 Oct;32(10):769-74. doi: 10.1136/emermed-2014-204235. Epub 2014 Dec 24.

PMID:
25539884
13.

Chest pain: if it hurts a lot, is heart attack more likely?

Body R, Lewis PS, Carley S, Burrows G, Haves B, Cook G.

Eur J Emerg Med. 2016 Apr;23(2):89-94. doi: 10.1097/MEJ.0000000000000218.

PMID:
25340995
14.

'Help us, she's fading away': How to manage the patient with anorexia nervosa.

Redston S, Tiller J, Schweitzer I, Keks N, Burrows G, Castle D, Newton JR.

Aust Fam Physician. 2014 Aug;43(8):531-6.

15.

Can emergency physicians 'rule in' and 'rule out' acute myocardial infarction with clinical judgement?

Body R, Cook G, Burrows G, Carley S, Lewis PS.

Emerg Med J. 2014 Nov;31(11):872-6. doi: 10.1136/emermed-2014-203832. Epub 2014 Jul 12.

PMID:
25016388
16.

Cerebrospinal fluid total protein cannot reliably distinguish true subarachnoid haemorrhage from other causes of raised cerebrospinal fluid net bilirubin and net oxyhaemoglobin absorbances.

Birch K, Burrows G, Cruickshank A, Egner W, Holbrook I, Lewis E, McNeilly J, Patel D, Worthington V.

Ann Clin Biochem. 2014 Nov;51(Pt 6):657-61. doi: 10.1177/0004563214538949. Epub 2014 May 20.

PMID:
24847134
17.

The Manchester Acute Coronary Syndromes (MACS) decision rule for suspected cardiac chest pain: derivation and external validation.

Body R, Carley S, McDowell G, Pemberton P, Burrows G, Cook G, Lewis PS, Smith A, Mackway-Jones K.

Heart. 2014 Sep 15;100(18):1462-8. doi: 10.1136/heartjnl-2014-305564. Epub 2014 Apr 29.

18.

HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis.

Meza-Romero R, Benedek G, Yu X, Mooney JL, Dahan R, Duvshani N, Bucala R, Offner H, Reiter Y, Burrows GG, Vandenbark AA.

J Immunol. 2014 May 1;192(9):4164-73. doi: 10.4049/jimmunol.1303118. Epub 2014 Mar 28.

19.

Drs Stagnell and Burrows respond.

Stagnell S, Burrows G.

Br Dent J. 2013 Dec;215(12):602. No abstract available.

PMID:
24505818
20.

Intrusive trichome bases in the leaves of silverleaf nightshade (Solanum elaeagnifolium; Solanaceae) do not facilitate fluorescent tracer uptake.

Burrows GE, White RG, Harper JD, Heady RD, Stanton RA, Zhu X, Wu H, Lemerle D.

Am J Bot. 2013 Dec;100(12):2307-17. doi: 10.3732/ajb.1300034. Epub 2013 Dec 9.

21.

Human multipotent adult progenitor cells transcriptionally regulate fucosyltransferase VII.

Burrows GG, Maziarz RT, Hunady K, Lehman N, Raber A, Deans RJ, Van't Hof W.

Cytotherapy. 2014 Apr;16(4):566-75. doi: 10.1016/j.jcyt.2013.08.004. Epub 2013 Oct 29.

PMID:
24176542
22.

Cojoined cementoma.

Stagnell S, Burrows G.

Br Dent J. 2013 Sep;215(6):267. doi: 10.1038/sj.bdj.2013.890. No abstract available.

PMID:
24072281
23.

Effective Arrestin-Specific Immunotherapy of Experimental Autoimmune Uveitis with RTL: A Prospect for Treatment of Human Uveitis.

Kyger M, Worley A, Huan J, McDowell H, Smith WC, Burrows GG, Mattapallil MJ, Caspi RR, Adamus G.

Transl Vis Sci Technol. 2013 Feb;2(2):1. Epub 2013 Feb 5.

24.

Dissection of the human multipotent adult progenitor cell secretome by proteomic analysis.

Burrows GG, Van't Hof W, Newell LF, Reddy A, Wilmarth PA, David LL, Raber A, Bogaerts A, Pinxteren J, Deans RJ, Maziarz RT.

Stem Cells Transl Med. 2013 Oct;2(10):745-57. doi: 10.5966/sctm.2013-0031. Epub 2013 Aug 27.

25.

Pharmacological approaches to the management of schizophrenia: 10 years on.

Castle D, Keks N, Newton R, Schweitzer I, Copolov D, Paoletti N, Burrows G, Tiller J.

Australas Psychiatry. 2013 Aug;21(4):329-34. doi: 10.1177/1039856213486211. Epub 2013 Apr 24. Review.

PMID:
23616381
26.

Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects.

Benedek G, Meza-Romero R, Andrew S, Leng L, Burrows GG, Bourdette D, Offner H, Bucala R, Vandenbark AA.

Eur J Immunol. 2013 May;43(5):1309-21. doi: 10.1002/eji.201243162. Epub 2013 Apr 10.

27.

Resprouting as a key functional trait: how buds, protection and resources drive persistence after fire.

Clarke PJ, Lawes MJ, Midgley JJ, Lamont BB, Ojeda F, Burrows GE, Enright NJ, Knox KJ.

New Phytol. 2013 Jan;197(1):19-35. doi: 10.1111/nph.12001. Epub 2012 Oct 30. Review.

28.

A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance.

Vandenbark AA, Meza-Romero R, Benedek G, Andrew S, Huan J, Chou YK, Buenafe AC, Dahan R, Reiter Y, Mooney JL, Offner H, Burrows GG.

J Autoimmun. 2013 Feb;40:96-110. doi: 10.1016/j.jaut.2012.08.004. Epub 2012 Sep 29.

29.

Systemic immunotherapy delays photoreceptor cell loss and prevents vascular pathology in Royal College of Surgeons rats.

Adamus G, Wang S, Kyger M, Worley A, Lu B, Burrows GG.

Mol Vis. 2012;18:2323-37. Epub 2012 Sep 6.

30.

Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.

Yadav V, Bourdette DN, Bowen JD, Lynch SG, Mattson D, Preiningerova J, Bever CT Jr, Simon J, Goldstein A, Burrows GG, Offner H, Ferro AJ, Vandenbark AA.

Autoimmune Dis. 2012;2012:954739. doi: 10.1155/2012/954739. Epub 2012 Apr 5.

31.

Gilt required for RTL550-CYS-MOG to treat experimental autoimmune encephalomyelitis.

Burrows GG, Meza-Romero R, Huan J, Sinha S, Mooney JL, Vandenbark AA, Offner H.

Metab Brain Dis. 2012 Jun;27(2):143-9. doi: 10.1007/s11011-012-9289-7. Epub 2012 Mar 7.

32.

Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.

Adamus G, Brown L, Andrew S, Meza-Romero R, Burrows GG, Vandenbark AA.

Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):406-12. doi: 10.1167/iovs.11-8419.

33.

Going beyond Kirkpatrick in evaluating a clinician scientist program: it's not "if it works" but "how it works".

Parker K, Burrows G, Nash H, Rosenblum ND.

Acad Med. 2011 Nov;86(11):1389-96. doi: 10.1097/ACM.0b013e31823053f3.

PMID:
21952054
34.

Elusive but not hypothetical: axillary meristems in Wollemia nobilis.

Burrows GE.

Ann Bot. 2012 Jan;109(1):1-2; discussion 3-4. doi: 10.1093/aob/mcr233. Epub 2011 Aug 24.

35.

RTL551 treatment of EAE reduces CD226 and T-bet+ CD4 T cells in periphery and prevents infiltration of T-bet+ IL-17, IFN-γ producing T cells into CNS.

Sinha S, Miller LM, Subramanian S, Burrows GG, Vandenbark AA, Offner H.

PLoS One. 2011;6(7):e21868. doi: 10.1371/journal.pone.0021868. Epub 2011 Jul 5.

36.

Eucalyptus regnans (Myrtaceae): A fire-sensitive eucalypt with a resprouter epicormic structure.

Waters DA, Burrows GE, Harper JD.

Am J Bot. 2010 Apr;97(4):545-56. doi: 10.3732/ajb.0900158. Epub 2010 Mar 11.

37.

Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice.

Dziennis S, Mader S, Akiyoshi K, Ren X, Ayala P, Burrows GG, Vandenbark AA, Herson PS, Hurn PD, Offner HA.

Metab Brain Dis. 2011 Jun;26(2):123-33. doi: 10.1007/s11011-011-9241-2. Epub 2011 Apr 7.

38.

TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes.

Dahan R, Tabul M, Chou YK, Meza-Romero R, Andrew S, Ferro AJ, Burrows GG, Offner H, Vandenbark AA, Reiter Y.

Eur J Immunol. 2011 May;41(5):1465-79. doi: 10.1002/eji.201041241. Epub 2011 Apr 12.

39.

Flammable biomes dominated by eucalypts originated at the Cretaceous-Palaeogene boundary.

Crisp MD, Burrows GE, Cook LG, Thornhill AH, Bowman DM.

Nat Commun. 2011 Feb 15;2:193. doi: 10.1038/ncomms1191.

PMID:
21326225
40.

Characterization of human platelet binding of recombinant T cell receptor ligand.

Itakura A, Aslan JE, Sinha S, White-Adams TC, Patel IA, Meza-Romero R, Vandenbark AA, Burrows GG, Offner H, McCarty OJ.

J Neuroinflammation. 2010 Nov 8;7:75. doi: 10.1186/1742-2094-7-75.

41.

RTL therapy for multiple sclerosis: a Phase I clinical study.

Offner H, Sinha S, Burrows GG, Ferro AJ, Vandenbark AA.

J Neuroimmunol. 2011 Feb;231(1-2):7-14. doi: 10.1016/j.jneuroim.2010.09.013. Epub 2010 Oct 20.

42.

Single-chain recombinant HLA-DQ2.5/peptide molecules block α2-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease.

Huan J, Meza-Romero R, Mooney JL, Vandenbark AA, Offner H, Burrows GG.

Mucosal Immunol. 2011 Jan;4(1):112-20. doi: 10.1038/mi.2010.44. Epub 2010 Aug 25.

43.

Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis.

Sinha S, Miller L, Subramanian S, McCarty OJ, Proctor T, Meza-Romero R, Huan J, Burrows GG, Vandenbark AA, Offner H.

J Neuroimmunol. 2010 Aug 25;225(1-2):52-61. doi: 10.1016/j.jneuroim.2010.04.013. Epub 2010 May 23.

44.

Dopamine D(1) receptor binding in the anterior cingulate cortex of patients with obsessive-compulsive disorder.

Olver JS, O'Keefe G, Jones GR, Burrows GD, Tochon-Danguy HJ, Ackermann U, Scott AM, Norman TR.

Psychiatry Res. 2010 Jul 30;183(1):85-8. doi: 10.1016/j.pscychresns.2010.04.004. Epub 2010 Jun 9.

PMID:
20538439
45.
46.

Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOG.

Sinha S, Subramanian S, Emerson-Webber A, Lindner M, Burrows GG, Grafe M, Linington C, Vandenbark AA, Bernard CC, Offner H.

J Neuroimmune Pharmacol. 2010 Jun;5(2):231-9. doi: 10.1007/s11481-009-9175-1. Epub 2009 Sep 30.

47.

Recombinant T cell receptor ligand treats experimental stroke.

Subramanian S, Zhang B, Kosaka Y, Burrows GG, Grafe MR, Vandenbark AA, Hurn PD, Offner H.

Stroke. 2009 Jul;40(7):2539-45. doi: 10.1161/STROKEAHA.108.543991. Epub 2009 May 14.

48.

Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligand.

Sinha S, Subramanian S, Miller L, Proctor TM, Roberts C, Burrows GG, Vandenbark AA, Offner H.

J Neurosci. 2009 Mar 25;29(12):3816-23. doi: 10.1523/JNEUROSCI.5812-08.2009.

49.
50.

Quetiapine augmentation in depressed patients with partial response to antidepressants.

Olver JS, Ignatiadis S, Maruff P, Burrows GD, Norman TR.

Hum Psychopharmacol. 2008 Dec;23(8):653-60. doi: 10.1002/hup.970.

PMID:
18816504

Supplemental Content

Loading ...
Support Center